1. Home
  2. INSE vs ALXO Comparison

INSE vs ALXO Comparison

Compare INSE & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspired Entertainment Inc.

INSE

Inspired Entertainment Inc.

HOLD

Current Price

$6.03

Market Cap

175.3M

Sector

Technology

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.97

Market Cap

205.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSE
ALXO
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.3M
205.9M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
INSE
ALXO
Price
$6.03
$1.97
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$14.00
$3.50
AVG Volume (30 Days)
116.3K
951.7K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.36
EPS
N/A
N/A
Revenue
$199,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
30.25
N/A
52 Week Low
$5.95
$0.80
52 Week High
$9.95
$2.66

Technical Indicators

Market Signals
Indicator
INSE
ALXO
Relative Strength Index (RSI) 30.68 48.50
Support Level N/A $1.93
Resistance Level $8.42 $2.21
Average True Range (ATR) 0.31 0.13
MACD -0.05 -0.01
Stochastic Oscillator 0.78 33.34

Price Performance

Historical Comparison
INSE
ALXO

About INSE Inspired Entertainment Inc.

Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: